Paper · 36085291
Comparison of the mutational profiles of neuroendocrine breast tumours, invasive ductal carcinomas and pancreatic neuroendocrine carcinomas.
Karihtala P and 7 others. Oncogenesis, 2022. Cited by 10 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Comparison of the mutational profiles of neuroendocrine breast tumours, invasive ductal carcinomas and pancreatic neuroendocrine carcinomas. Papers, record 36085291. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36085291
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparison of the mutational profiles of neuroendocrine breast tumours, invasive ductal carcinomas and pancreatic neuroendocrine carcinomas.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28,394,898 | Prognostic and clinicopathological value of GATA binding protein 3 in breast cancer: A systematic review and meta-analysis. | PLoS One | 2017 | https://conductscience.org/library/papers/28394898 | PubMed |
| 2 | 23,325,621 | CRAVAT: cancer-related analysis of variants toolkit. | Bioinformatics | 2013 | https://conductscience.org/library/papers/23325621 | PubMed |
| 3 | 31,068,675 | Preferential sensitivity to HDAC inhibitors in tumors with CREBBP mutation. | Cancer Gene Ther | 2020 | https://conductscience.org/library/papers/31068675 | PubMed |
| 4 | 27,060,254 | Coenzyme Q biosynthesis in health and disease. | Biochim Biophys Acta | 2016 | https://conductscience.org/library/papers/27060254 | PubMed |
| 5 | 24,589,259 | Invasive neuroendocrine carcinoma of the breast: a population-based study from the surveillance, epidemiology and end results (SEER) database. | BMC Cancer | 2014 | https://conductscience.org/library/papers/24589259 | PubMed |
| 6 | 30,282,082 | Neuroendocrine Breast Carcinomas Share Prognostic Factors with Gastroenteropancreatic Neuroendocrine Tumors: A Putative Prognostic Role of Menin, p27, and SSTR-2A. | Oncology | 2019 | https://conductscience.org/library/papers/30282082 | PubMed |
| 7 | 31,368,038 | Clinical applications of (epi)genetics in gastroenteropancreatic neuroendocrine neoplasms: Moving towards liquid biopsies. | Rev Endocr Metab Disord | 2019 | https://conductscience.org/library/papers/31368038 | PubMed |
| 8 | 29,417,298 | Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review. | Breast Cancer Res Treat | 2018 | https://conductscience.org/library/papers/29417298 | PubMed |
| 9 | 30,181,244 | Crebbp Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC Inhibition. | Cancer Discov | 2018 | https://conductscience.org/library/papers/30181244 | PubMed |
| 10 | 28,199,314 | Whole-genome landscape of pancreatic neuroendocrine tumours. | Nature | 2017 | https://conductscience.org/library/papers/28199314 | PubMed |
1 to 10 of 51
See all 51 referencesCited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,621,194 | Long-term survival and molecular heterogeneity of sporadic multifocal non-functional pancreatic neuroendocrine tumors. | iScience | 2026 | https://conductscience.org/library/papers/42621194 | PubMed |
| 41,243,501 | HER2-positive neuroendocrine breast carcinoma: a case study uncovers CCND1, FGF19, and IGF1R amplifications as new molecular drivers. | Pathologica | 2025 | https://conductscience.org/library/papers/41243501 | PubMed |
| 40,565,246 | The ADCK Kinase Family: Key Regulators of Bioenergetics and Mitochondrial Function and Their Implications in Human Cancers. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40565246 | PubMed |
| 39,856,067 | Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypes. | NPJ Breast Cancer | 2025 | https://conductscience.org/library/papers/39856067 | PubMed |
| 39,134,585 | Somatic mutational landscape across Indian breast cancer cases by whole exome sequencing. | Sci Rep | 2024 | https://conductscience.org/library/papers/39134585 | PubMed |
| 38,958,708 | A morphological and immunohistochemical study of ductal carcinoma in situ, invasive breast carcinoma of no special type, and mucinous carcinoma of the breast in comparison with solid papillary carcinoma regarding neuroendocrine marker expression. | Virchows Arch | 2024 | https://conductscience.org/library/papers/38958708 | PubMed |
| 38,800,403 | Comparison of clinical characteristics and outcomes in primary neuroendocrine breast carcinoma versus invasive ductal carcinoma. | Front Oncol | 2024 | https://conductscience.org/library/papers/38800403 | PubMed |
Genes31
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ADCK2 | 90,956 | PubTator's text mining | https://conductscience.org/library/genes/90956 | NCBI Gene |
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| ATRX | 546 | PubTator's text mining | https://conductscience.org/library/genes/546 | NCBI Gene |
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 | NCBI Gene |
| CHGA | 1,113 | PubTator's text mining | https://conductscience.org/library/genes/1113 | NCBI Gene |
| CREBBP | 1,387 | PubTator's text mining | https://conductscience.org/library/genes/1387 | NCBI Gene |
| DAXX | 1,616 | PubTator's text mining | https://conductscience.org/library/genes/1616 | NCBI Gene |
| DMD | 1,756 | PubTator's text mining | https://conductscience.org/library/genes/1756 | NCBI Gene |
| EP400 | 57,634 | PubTator's text mining | https://conductscience.org/library/genes/57634 | NCBI Gene |
| ERBB2 | 2,064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
1 to 10 of 31
See all 31 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36085291
GET https://conductscience.org/api/papers/v1/36085291/references?page=2